Misdiagnosing autoimmune diseases as psychiatric conditions can lead to long-term damage to patients' health and trust in ...

Moore, MD, discusses the exciting advancements in endometrial cancer treatment, particularly over the past 2 years, as she prepares for the 2025 Society of Gynecologic Oncology Annual Meeting on Women ...

Dr Kathleen Moore provides SGO 2025 highlights, including anticipated presentations, quick takeaways, and insights into how ...

Dr Annalisa Morgan reflects on new data on DMTs for RRMS that highlighted the potential of BTK inhibitors such as ...

Renal cell carcinoma highlights from ASCO GU 2025 include follow-up data from the CheckMate 9ER study, updated COSMIC-313 results, and promising early data on casdatifan, a new HIF-2 alpha inhibitor.

Fast-evolving tech makes hospital-at-home an approaching reality. Although not everyone is a fan, the future potential is ...

Cite this: What's Next? Clinical Trials in Myelofibrosis - Medscape - Mar 06, 2025.

Studies suggest types of fasting can lead to moderate weight loss and other health benefits in overweight and obese people, ...

High-parameter flow cytometry of peripheral blood mononuclear cells enabled physicians to treat recalcitrant erythroderma in ...

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...

Perioperative optimization of nutrition leads to lower risks, better outcomes, and improved quality of life for patients.

De-escalating dual antiplatelet therapy from from aspirin plus ticagrelor to aspirin plus clopidogrel after primary ...